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Article focus
  In our clinical practice, we had frequently 
encountered patients with metal-on-
metal (MoM) total hip arthroplasties 
(THAs) with greater concentrations of 
cobalt (Co) in their hip synovial fluid sam-
ples than patients with equivalent MoM 
hip resurfacing designs.
  However, examination of explanted 
devices indicated significantly lower total 
wear rates in the THA group.
  We hypothesized that the presence and 
severity of the aseptic lymphocyte- 
dominated vasculitis-associated lesion 
(AlvAl) response in periprosthetic tissue 
may influence, or be influenced by, the rate 
of clearance of metal from the joint fluid.
Key messages
  After adjustment for volumetric wear rates, 
severe AlvAl was associated with greater 
Co and chromium (Cr) concentrations in 
Aseptic lymphocyte-dominated vasculitis-
associated lesions are related to changes 
in metal ion handling in the joint capsules 
of metal-on-metal hip arthroplasties
Objectives
We have encountered patients who developed large joint fluid collections with massive ele-
vations in chromium (cr) and cobalt (co) concentrations following metal-on-metal (MoM) 
hip arthroplasties. In some cases, retrieval analysis determined that these ion concentrations 
could not be explained simply by the wear rates of the components. We hypothesized that 
these effects may be associated with aseptic lymphocyte-dominated vasculitis-associated 
lesion (ALVAL).
Patients and Methods
We examined the influence of the ALVAL grade on synovial fluid co and cr concentrations 
following adjustment for patient and device variables, including volumetric wear rates. Ini-
tially restricting the analysis to include only patients with one MoM hip resurfacing device, 
we performed multiple regression analyses of prospectively collected data. We then repeated 
the same statistical approach using results from a larger cohort with different MoM designs, 
including total hip arthroplasties.
Results
In the resurfacing cohort (n = 76), the statistical modelling indicated that the presence of 
severe ALVAL and a large fluid collection were associated with greater joint fluid co concen-
trations after adjustment for volumetric wear rates (p = 0.005). These findings were repli-
cated in the mixed implant group (n = 178), where the presence of severe ALVAL and a large 
fluid collection were significantly associated with greater fluid co concentrations (p < 0.001).
Conclusion
The development of severe ALVAL is associated with elevations in metal ion concentrations 
far beyond those expected from the volumetric loss from the prosthetic surfaces. This find-
ing may aid the understanding of the sequence of events leading to soft-tissue reactions 
following MoM hip arthroplasties.
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synovial fluid samples compared with samples taken 
from patients without severe AlvAl.
  After adjustment for wear rates, the presence of a 
large fluid collection was also associated with greater 
concentrations of metal in synovial fluid, rather than a 
reduction as might be expected via the effects of 
dilution.
  The findings indicate that AlvAl and fluid collections 
are associated with impaired clearance of metal debris 
from the joint capsule.
Strengths and limitations
  The study describes novel findings in a large sample 
size involving patients with resurfacing and THAs.
  While an association between AlvAl and changes in 
metal handling have been identified, cause or effect 
cannot be determined.
introduction
For several years, a cohort of patients implanted with one 
type of metal-on-metal (MoM) hip arthroplasty, the 
Articular Surface Replacement (ASR) (DePuy Synthes, 
Warsaw, Indiana) have been followed up in our institu-
tion. The ASR was available in two forms, the ASR resur-
facing and the ASR Xl total hip arthroplasty (THA), 
though both of these implants have been withdrawn 
since 2010. However, we have continued to investigate 
the relationship between the wear of MoM prostheses, 
periprosthetic cellular responses and clinical outcomes.
Many patients have been encountered who developed 
large joint effusions containing massive concentrations of 
chromium (Cr) and cobalt (Co) metal ions.1 Yet, in some 
cases, most commonly ASR Xl THA patients, retrieval anal-
ysis determined that the Cr and Co ion concentrations 
were higher than would be expected from the actual 
amount of material loss from the components. Further-
more, it was found that patients implanted with the ASR Xl 
THA experienced an adverse reaction to metal debris 
(ARMD)-related failure at a rate double to that of patients 
implanted with ASR resurfacings.1 The reactions tended to 
be more severe in the THA patients yet, on average, they 
were exposed to significantly less volumetric wear than 
the resurfacing patients (Table I). Paradoxically, the 
median Co concentration in the synovial fluid samples of 
the THA patients was higher than that in the resurfacing 
patients. These observations prompted us to investigate 
the differences in synovial fluid biochemistry associated 
with metal debris generated from bearings, compared 
with that from the head taper.2
Contrary to our expectations though, we found that 
metal debris release from the taper junction was not 
associated with significantly greater Co concentrations in 
the joint when matched by dose to bearing debris.2 We 
speculated, therefore, that these variations in metal ion 
concentrations might be associated with changes in the 
cellular environment in the joint capsule, specifically the 
grade of aseptic lymphocyte-dominated associated lesion 
(AlvAl).4
our primary hypothesis for this investigation, there-
fore, was that fluid samples taken from hip joints with 
higher grade AlvAl scores would contain greater Co 
concentrations than those taken from joints with lower 
grade AlvAl, after adjustment for wear rates. our sec-
ondary hypothesis was that, like AlvAl, larger fluid col-
lections would also be associated with greater Co 
concentrations than small fluid collections exposed to 
similar amounts of metal debris.
Patients and Methods
Since 2008, patients who experience failure of MoM hip 
prostheses at our centre routinely undergo pre-revision 
blood and hip joint synovial fluid Co and Cr ion meas-
urements. Tissue samples excised at revision surgery are 
assessed by a pathologist (SN).5 Explanted prostheses 
are analyzed to determine volumetric material loss from 
the bearing and female taper surfaces.2 In order to 
exclude the contribution of taper junction debris, and 
variations in metallurgy between designs,2 we initially 
included only ASR hip resurfacings with recorded volu-
metric wear rates, corresponding joint fluid metal ion 
concentrations and documented AlvAl grades. Patients 
with incomplete data sets were excluded.
Table i. Details of the Articular Surface Replacement (ASR) resurfacing and Xl patients revised at our unit. The whole cohorts have been described in detail in 
previous publications1,3
Resurfacings ASR THAs Significance
Hips, n 76 45  
Age (yrs)* 54 56 0.061†
Male:female 33:43 14:29 0.239‡
Total volumetric wear rate (mm3 per yr)* 7.10 3.26 0.001†
Joint fluid Cr (µg/l)* 1622 562 0.024†
Joint fluid Co (µg/l)* 855 1192 0.812†
AlvAl grade 3 (severe), % 17 26 0.290‡
Soft-tissue injury grade 3 (severe), % 9 35 0.001‡
*median value
†Mann-Whitney U test
‡Fisher’s exact test
THA, total hip arthroplasty; Cr, chromium; Co, cobalt; AlvAl, aseptic lymphocyte-dominated vasculitis-associated lesion
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The study was part of an ethically approved project 
(IRAS reference 14119).
Histopathological tissue assessment. Samples were 
taken from between two and four sites surrounding the 
implant. Up to ten paraffin blocks were processed per 
site to ensure the viable tissue was well represented. 
Samples were also sent to the microbiology depart-
ment to rule out sepsis. A single consultant histopathol-
ogist (SN), examined the slides independently of the 
clinical findings, blinded to the results of the wear or 
fluid metal ion analyses. The size of aggregated particle 
masses was recorded as has been described.2 In 2011, 
the significant correlation between the mean diameter 
of lymphocytic perivascular cuffs and the extent of 
synovial membrane necrosis was reported,6 along with 
the variation in cellular responses to MoM prostheses.5 
The grading system used in this paper (the NTH grad-
ing system) is standard and used in clinical practice for 
all MoM cases. The AlvAl response was graded from 
0 (absent) to 3 (severe) according to the integrity of 
the synovial membrane and the stage of lymphocytic 
infiltration (Figs 1 to 3, Table II and supplementary 
material).
Synovial membrane. The extent of synovial surface necro-
sis was recorded as type 1 to 4, as described originally by 
Davies et al4 and later modified by us.5
Lymphocytic cuffs. The development of perivascular lym-
phocytic cuffs appears to be a dynamic process.5 Thin 
perivascular cuffs initially appear which increase in thick-
ness as the recruitment of lymphocytes is further stim-
ulated. These cuffs then either expand to develop into 
aggregates or coalesce into one another, forming larger 
aggregates. once this process of lymphoid neogenesis is 
complete, pale germinal centres appear.
The differences between the AlvAl grading system 
used in the current paper and those used in previous pub-
lications7,8 are discussed in the supplementary material.
Wear analysis. Explanted prostheses were analyzed using 
a coordinate measuring machine (legex 322; Mitutoyo 
ltd, Halifax, United Kingdom) to calculate the total 
amount of material that had been removed from the com-
ponents in vivo. This material loss can be expressed in 
volumetric terms as ‘total volumetric wear’ (in mm3) or 
the total value can be divided by the number of years in 
vivo to provide a mean ‘volumetric wear rate’ (expressed 
in mm3/year). The accuracy of such methods has been 
validated and is of the order of 0.5 mm3 per component 
for bearings and 0.2 mm3 for tapers.2,9 Throughout this 
paper, wear rates refer only to volumetric Co-Cr material 
loss. For resurfacings, ‘total volumetric wear rates’ refer 
Fig. 1
Histology showing grade 1 (mild) aseptic lymphocyte-dominated vasculitis-
associated lesion (AlvAl). There is fibrin deposition on the surface membrane 
with minimal necrosis (unbroken arrow). Macrophages are present, with visi-
ble metal debris (thin, unbroken line). There are thin perivascular lymphocytic 
cuffs forming aggregates but not follicles (broken arrow).
Fig. 2
Histology showing grade 2 (moderate) aseptic lymphocyte-dominated vascu-
litis-associated lesion. There is fibrin deposition as well as necrosis of the sur-
face membrane (unbroken arrow). Sheets of macrophages containing metal 
debris are visible (thin, unbroken line). lymphoid aggregates are present but 
there is no follicle formation (broken arrow).
Fig. 3
Histology showing grade 3 (severe) aseptic lymphocyte-dominated vasculitis-
associated lesion. There are coalescing perivascular lymphocytic aggregates 
and development of lymphoid follicles (broken arrow). There is extensive sur-
face necrosis (unbroken arrow) and sheets of macrophages containing metal 
debris (thin, unbroken line).
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to the bearing surface wear rates (combined head and 
acetabular component volumetric wear rates). For THAs, 
‘total volumetric wear rates’ refer to the combined wear 
rates of the bearings and female taper surface.
Joint fluid Co and Cr concentrations. Prior to revision sur-
gery, joint fluid was extracted under local anaesthetic to 
rule out infection and to analyze the Co and Cr concen-
trations. Metal ion concentrations were measured using 
inductively coupled plasma mass spectrometry (ICPMS) 
at the Royal Surrey Hospital. Samples did not undergo 
acid digestion prior to ICPMS analysis2 (supplementary 
material).
Fluid at revision surgery. The amount of fluid observed at 
revision was categorized as described previously,2 albeit 
this time using a binary approach. Findings of no abnor-
mal fluid or ‘small’ collections of fluid were designated 
‘small’. Joints with copious amounts of abnormal fluid 
(approximately > 20 mls) or those found to have pressur-
ized fluid or fistulation of fluid were designated ‘large’.
Statistical analysis. Initially, the distribution of blood and 
joint Co and Cr concentrations, as well as volumetric wear 
rates from the bearing and taper surface, were examined 
using the Shapiro-Wilk test. All values were determined 
to be non-parametrically distributed (p < 0.001 for all 
tests) and were therefore log normalized. Forwards and 
backwards stepwise multiple regression models (includ-
ing forwards and backwards stepwise approaches) were 
constructed to investigate whether any differences in 
the joint Co and Cr concentrations were brought about 
due to differences in the AlvAl grade. Statistical analy-
sis was carried out using Minitab v17 software (Minitab 
ltd, Coventry, United Kingdom). For completeness, and 
to rule in or out effects of dilution in larger patients, we 
included other continuous and categorical variables as 
shown in Table III. our previous investigations showed 
these variables to have limited, if any, influence on the 
relationship between wear and ion concentrations.2
Fluid and ALVAL synergy. We noted in our previous 
investigations the positive correlation between higher 
grades of AlvAl and larger joint fluid collections at revi-
sion.6 In order to investigate a potential synergistic effect 
between AlvAl and fluid development, two groups of 
patients were selected from the data. The first consisted 
of patients with both severe AlvAl and large fluid col-
lections. The second was composed of patients with no/
mild/moderate AlvAl with small fluid collections. The 
regression models were repeated, this time directly com-
paring these two groups.
Mixed implant cohort. In the final part of this investiga-
tion, we took the data from all other MoM patients revised 
at our centre with documented explant analysis, AlvAl, 
fluid grades and joint fluid metal ion concentrations. only 
implants with cobalt-chromium-molybdenum (CoCrMo) 
bearings were included and, if a THA construct, only 
those used with uncemented titanium femoral stems. 
Patients were excluded only if data sets were incomplete. 
We repeated the statistical tests to determine whether the 
same relationships between AlvAl, wear and joint Co con-
centrations identified in the ASR resurfacing cohort existed 
in this larger sample of patients. Cr concentrations were 
not included in these tests as previous investigations have 
shown that, with debris released from taper junctions, 
there is a tendency for Cr to adhere to the taper surface.2
The statistical models reported are those that best 
described the response variables where all the coeffi-
cients of the explanatory variables were significantly dif-
ferent from 0, with significance drawn at a p-value < 
0.05. Standardized beta coefficients are reported as β 
with standard error as SE. The power of statistical models 
to explain variation in the dependent variables is reported 
as percentages throughout (these percentages are equiv-
alent to R2 values).
We also conducted three small parallel studies which 
are described in the supplementary material. The first 
Table iii. variables included in the regression models
Predictors Dependent variables
Patient factors Joint fluid Co†
 Joint fluid Cr†
Age at primary  
Gender*  
Bilateral devices*  
Cellular environment:  
AlvAl grade*  
Agglomerated particle grade*  
Device factors:  
Total volumetric wear rate†  
Duration in vivo  
Dilutional effects:  
Acetabular component size  
Fluid grade*  
*categorical variables
†log normalized values used in the analysis
Co, cobalt; Cr, chromium; AlvAl, aseptic lymphocyte-dominated vasculitis-
associated lesion
Table ii. NTH aseptic lymphocyte-dominated vasculitis-associated lesion (AlvAl) grading system. The development of the grading system, interobserver reli-
ability scores and comparison with other grading systems are described in the supplementary material
Grade 0: ALVAL absent Grade 1: Mild ALVAL Grade 2: Moderate ALVAL Grade 3: Severe ALVAL
vascular cuffs None Yes large perivascular lymphocytic 
aggregates
large confluent lymphocytic 
aggregates
Synovial membrane Intact Grade 0 or 1 Grade 2 or 3 Grade 4
Hyalinization No No Can be present Present
Germinal centres No No Can be present Present
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study aimed to quantify the changes in joint fluid metal 
ion concentrations following acid digestion of samples. 
The second was intended simply to characterize the 
nature of fluid effusions as having normal or abnormal 
albumin concentrations. The third was a basic theoretical 
study to demonstrate how the effect of changes in fluid 
volumes would be expected to affect joint fluid metal ion 
concentrations.
Results
A total of 76 explanted ASR devices were included in the 
first analysis. There were 178 explants in the mixed 
implant cohort. Patient demographic, clinical parameters 
and implant details are shown in Table Iv.
ALVAL and joint fluid Co concentrations. In the best-fit-
ting regression model, total wear rate was the dominant 
variable (β = 0.669, SE = 0.08, p < 0.001). Joints with 
grade 3 (severe) AlvAl were significantly associated with 
greater Co concentrations than those with grade 0, 1 or 
2 AlvAl (p = 0.05, p = 0.012, p = 0.005, respectively) 
(Fig. 4). Smaller fluid collections were significantly asso-
ciated with lower Co concentrations (β = -0.240, SE = 
0.083, p = 0.005). A longer duration in vivo was asso-
ciated with greater Co concentrations (β = 0.180, SE = 
0.085, p = 0.038) and there was a trend for larger joints 
to have lower Co concentrations (β = -0.157, SE = 0.084, 
p = 0.068). These variables accounted for approximately 
62% of the variation in Co (p < 0.001). The equation for 
the best-fit model was: log joint Co = 3.824 - (0.031 × 
acetabular component size) + (0.007 × duration in vivo) 
+ (0.891 × log wear) - (0.412 if AlvAl absent) - (0.453 if 
AlvAl mild) - (0.438 if AlvAl moderate) - (0.388 if small 
fluid collection).
ALVAL and fluid synergy with Co. The influence of the 
combined effect of a large fluid collection and severe 
AlvAl on joint fluid Co can be seen in Figure 5. Total 
wear rate was again the dominant variable (β = 0.530, 
SE = 0.112, p < 0.001), however, the presence of a large 
fluid collection with severe AlvAl had a comparable influ-
ence (β = 0.502, SE = 0.112, p < 0.001). The equation of 
the best-fit regression model was: log joint Co = 2.721 + 
0.816 × log total volumetric wear - (0.846 if small fluid 
collection and non-severe AlvAl). This model provided 
approximately 67% of the variation in the joint Co con-
centrations. Essentially, the effect of the presence of a 
large fluid collection and severe AlvAl was to increase 
the fluid Co concentrations as if the volumetric wear rate 
had increased by approximately 7 mm3 per year.
ALVAL and joint fluid Cr concentrations. In the best-fitting 
regression model, total wear rate was the dominant vari-
able (β = 0.765, SE = 0.071, p < 0.001). Joints with small 
fluid collections were significantly associated with lower 
Table iV. Details of the patient cohorts included in the investigation of the influence of aseptic lymphocyte-dominated vasculitis-associated lesion (AlvAl) on 
joint fluid metal ion concentrations
ASR resurfacings Mixed implant cohort
Hips, n 76 178
Device type ASR resurfacings 36 mm MoM: 105
 ASR Xl: 45
 BHR resurfacings: 26
 Durom resurfacings: 2
Age (yrs)* 54 (29 to 75) 59 (22 to 84)
Male:female 33:43 53:125
Total volumetric wear rate (mm3 per yr)* 7.10 (0.62 to 95.5) 2.28 (0.23 to 69.1)
Duration in vivo (mths)* 54 (8 to 108) 61 (11 to 136)
Acetabular component size (mm)* 54 (46 to 64) 53 (44 to 64)
Joint fluid Cr (µg/l)* 1622 (26 to 195 947) 455 (13 to 133 120)
Joint fluid Co (µg/l)* 855 (26 to51 487) 605 (9 to 46 433)
AlvAl grade 3 (severe), % 17 22
Ratio of small:large fluid collection: 20:56 49:129
*median values
ASR, Articular Surface Replacement; MoM, metal-on-metal; BHR, Birmingham Hip Resurfacing; Cr, chromium; Co, cobalt
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Fig. 4
Articular Surface Replacement resurfacing patients. Best-fit regression lines 
for the relationship between logged values of fluid cobalt (Co) and volumetric 
wear, for each grade of aseptic lymphocyte-dominated vasculitis-associated 
lesion.
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Cr concentrations than those with large fluid collections 
(β = -0.159, SE = 0.071, p = 0.030). Neither AlvAl, nor 
any of the other examined variables, was found to have 
significant influences, with wear rate and fluid providing 
approximately 63% of the variation in the fluid Cr con-
centration. The equation for the best-fit model was: log 
joint Cr = 2.303 + 1.192 × log wear rate (- 0.301 if small 
fluid collection).
ALVAL and fluid synergy with Cr. As was observed with 
Co, the presence of severe AlvAl and a large fluid col-
lection was associated with significantly larger Cr con-
centrations, however, this effect was less powerful. The 
equation for the best-fit regression model was: log joint 
Cr = 2.489 + 1.098 × log wear rate - 0.440 × (absent to 
moderate AlvAl and small fluid collection) (Fig. 6). This 
model provided approximately 64% of the variation in 
Cr. Beta coefficients for these variables were 0.697 (SE = 
0.117, p < 0.001) for volumetric wear rate and 0.255 
(SE = 0.117, p = 0.038) for the presence of severe AlvAl 
with a large fluid collection.
Mixed implant cohort. In the best-fitting regression 
model, wear rate was the dominant variable (β = 0.562, 
SE = 0.06, p < 0.001). Joints with grade 0 (absent) 
AlvAl were significantly associated with lower Co con-
centrations than those with grade 3 (severe) AlvAl (β = 
-0.210, SE = 0.078, p = 0.007), as were those with mild 
AlvAl (β = - 0.180, SE = 0.080, p = 0.020) (Fig. 7). In 
this cohort, the moderate AlvAl group were not found 
to have significantly lower joint Co concentrations than 
the severe group (β = 0.124, SE = 0.080, p = 0.121). 
There was no significant difference in Co concentrations 
between the patients with small and large fluid collec-
tions (p = 0.688).
The combined influence of a large fluid collection and 
severe AlvAl on joint fluid Co can be seen in Figure 8. 
Wear rate was again the dominant variable (β = 0.516, 
SE = 0.094, p < 0.001). The presence of a large fluid col-
lection with severe AlvAl had a weaker influence 
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Fig. 5
In this chart, the Articular Surface Replacement resurfacing patients have been 
placed into two groups: those with severe aseptic lymphocyte- dominated 
vasculitis-associated lesion (AlvAl) and a large fluid collection (n = 12, red); 
and those with absent/mild/moderate AlvAl and a small fluid collection (n = 
19, blue). The regression modelling demonstrated that patients with severe 
AlvAl and large fluid collections were found to have greater cobalt (Co) con-
centrations when adjusted for volumetric wear rates.
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In this chart, the Articular Surface Replacement resurfacing patients have been 
placed into two groups: those with severe aseptic lymphocyte- dominated 
vasculitis-associated lesion (AlvAl) and a large fluid collection (n = 12, red); 
and those with absent/mild/moderate AlvAl and a small fluid collection (n = 
19, blue). The regression modelling demonstrated that patients with severe 
AlvAl and large fluid collections were found to have greater chromium (Cr) 
concentrations when adjusted for volumetric wear rates.
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Mixed implant cohort. Best-fit regression lines for the relationship between 
logged values of fluid cobalt (Co) and volumetric wear, for each grade of asep-
tic lymphocyte-dominated vasculitis-associated lesion.
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(β = 0.239, SE = 0.094, p < 0.001) than the resurfacing 
only group. The equation of the best-fit regression model 
was: log joint Co = 2.346 + 0.799 × log wear rate + 
(0.340 if large fluid collection and severe AlvAl).
Discussion
We hypothesized that patients with AlvAl and large fluid 
effusions would have greater joint fluid metal ion con-
centrations when compared with patients with implants 
wearing at similar rates who had not developed AlvAl. 
Initially limiting our investigation to patients with one 
type of hip resurfacing, then expanding it to include dif-
ferent designs and modular devices, we have shown that 
the accumulation of Co ions in joint fluid is more pro-
nounced than Cr.
‘Normal’ wear and synovial fluid ion concentrations. The 
standard CoCrMo alloy from which contemporary MoM 
prostheses are manufactured is composed, by weight, 
of approximately 65% Co and 30% Cr.2 Yet the most 
frequent biochemical picture encountered in patients 
with hip resurfacings is that of a synovial fluid rich in 
Cr.10 There can only be two explanations for this find-
ing. The first is that there is a selective release of Cr from 
the prosthetic surfaces. However, as the volume loss can 
often be greater than 100 mm3,6 this explanation seems 
implausible. It is more likely, therefore, that there is a dif-
ference in the host’s capacity to clear the two different 
types of metal from the joint. Multiple hip simulator stud-
ies have indicated that larger particles generated from 
MoM bearing surfaces are composed predominantly of 
Cr, in the form of chromium dioxide.11,12 This has been 
substantiated by the examination of ex vivo fluid samples, 
analyzed pre- and post-acid digestion.13 Analysis of a hip 
fluid sample taken from a patient experiencing high wear 
of their MoM prosthesis, with a characteristic Cr-rich bio-
chemistry (Cr = 15 200 µg/l; Co = 7,900 µg/l), found that 
the median (range) Co particle diameter was 39 nm (32 
to 136), with the Cr particles being significantly larger.14 
The cell layer of the synovial lining is discontinuous, with 
the intercellular space of the acetabular component filled 
with a complex interstitial matrix. This matrix has an esti-
mated pore diameter of 30 nm to 118 nm and can act 
as a size-selective barrier.15 The size of particulate matter, 
therefore, affects the route and therefore, the rate, of its 
clearance from synovial fluid.16 Thus we speculate that 
the clearance of Cr occurs more slowly due to its lower 
solubility, greater average particle size and thus greater 
dependence on the lymphatic channels. We propose that 
this situation explains why MoM joint with minimal syno-
vial membrane damage contain synovial fluid, which is 
typically rich in Cr, a finding which, we suggest, may be 
considered ‘normal’.
When Co concentrations rise in excess of the Cr con-
centration in joint fluid, it may be indicative of a distur-
bance in the normal function of the synovial membrane, 
a change in the composition or volume of the joint fluid, 
a change in the protein binding of the metal debris or a 
change in the rate, composition or morphology of the 
debris generated by the prosthesis.
Changes in particle size. Metal ion concentrations in this 
study were measured using fluid samples which had not 
undergone acid digestion prior to ICPMS. It is, therefore, 
conceivable that in situations where a greater proportion 
of metal debris was shed from the components in ionic 
form, the measured Cr and Co concentrations could be 
larger than those measured in a patient with a prosthesis 
wearing at the same rate but generating larger particles. 
Therefore, if AlvAl is stimulated by exposure to smaller 
particles, the relationships we have observed could be 
representative of the promotion of the cellular response 
rather than AlvAl itself causing the changes in biochem-
istry. However, acid digestion has a much greater effect 
on Cr than on Co,13 and, in the current study, severe 
AlvAl was associated primarily with elevations of Co 
rather than Cr.
Changes in the rate of metal debris generation. The wear 
rates we have quoted and used in the statistical analy-
ses are mean annual wear rates, but it is possible that 
implants could experience rapid increases in wear prior 
to revision. This could occur, for example, when a wear 
patch extends to incorporate the edge of the bearing 
surface, or, with THAs, when micromotions at the taper 
interface become progressively greater in magnitude. 
From our data, we were not able to identify fluctuations 
in wear rates. This is an important area for future research 
as a rapid increase in metal debris release could in fact 
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In this chart, the mixed implant cohort patients have been placed into 
two groups: those with severe aseptic lymphocyte-dominated vasculitis- 
associated lesion (AlvAl) and a large fluid collection (n = 34, red); and those 
with absent/mild/moderate AlvAl and a small fluid collection (n = 44, blue). 
The regression modelling demonstrated that patients with severe AlvAl and 
large fluid collections were found to have greater cobalt (Co) concentrations 
when adjusted for volumetric wear rates.
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be the immune stimulus leading to the development of 
AlvAl.
Changes to synovial membrane function. As described 
above, the synovial membrane plays an important role 
in solute transit. Severe AlvAl, by definition, indicates 
severe disruption to the regulation of the blood joint bar-
rier, with widespread necrosis of the synovial membrane. 
It seems only logical, therefore, that such severe destruc-
tion to this complex structure could result in the potential 
impairment of metal ion clearance.
Synovial fluid changes. one of the classical findings of 
ARMD is the development of large fluid collections in the 
joint which can frequently reach volumes many times 
larger than those reported in healthy hip joints (< 5 ml).17 
In the patients in this study, the presence of AlvAl and 
the development of fluid collections appeared to be inti-
mately linked. of the 186 patients with ‘large’ joint effu-
sions, only 19 (10%) had no features of AlvAl. of the 
139 patients with moderate/severe AlvAl, 115 (83%) 
had ‘large’ fluid collections. The composition of ARMD-
related fluid collections has not, to our knowledge, 
been fully characterized. our early findings (described 
in the supplementary material) demonstrate that these 
effusions, as with those found in other inflammatory 
conditions, contain excess concentrations of albumin, 
indicating a breakdown in the regulation of protein trans-
port at the blood-joint barrier. For larger solutes such as 
albumin, the barrier between the blood and the joint 
resides mainly in the small pores of the endothelial layer 
of vessels which restrict protein exchange far more than 
the intimal matrix.18 Hallmark features of AlvAl include 
the development of perivascular lymphocytic aggregates 
and associated changes to the vessel walls. The changes in 
vessel wall permeability, combined with structural dam-
age to the synovial membrane seen in advanced cases of 
AlvAl could, therefore, lead to changes in protein flux 
via leakage of protein through vessel walls or a reduction 
in the rate of fluid/albumin egress from the joint.
Changes in metal protein binding. The results presented 
in this paper show that the development of fluid col-
lections leads to an increase in local metal ion concen-
trations rather than a decrease, as might be expected 
secondary to dilution (supplementary material). We have 
previously shown evidence that in aspirated hip fluid, Co 
and Cr ions are primarily bound to albumin and trans-
ferrin, respectively.14 In studies of drug delivery to the 
knee joint, it has been demonstrated that the binding of 
solutes to proteins in synovial fluid retards their trans-
port out of the joint space.19 We believe, therefore, the 
most likely explanation for the accummulation of Co in 
the fluid samples is secondary to an increase in the pro-
portion of Co which is protein bound. The clinical mean-
ing of the effects of increases in fluid protein content, 
coupled with rising metal concentrations, is unclear. In 
theory, this environment could lead to the concentration 
of metalloproteins which may be recognized as ‘foreign’ 
by the host. The presence of metals other than Co and Cr, 
such as Mo, may also prove to be of greater significance 
in this respect than has previously been recognized.
In conclusion we have shown that the development of 
severe AlvAl is associated with elevations in metal ion 
concentrations far beyond those expected from volumet-
ric loss from the prosthetic surfaces. It is also apparent 
that there is a complex interaction between AlvAl, joint 
fluid protein homeostasis and metal ion handling. We are 
currently unable to determine whether the changes in 
metal ion handling are caused by the presence of AlvAl 
or vice versa.
Supplementary material
The development of the grading system, interob-
server reliability scores and comparison with other 
grading systems.
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